

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.30770531 |
| 2 | central nervous system myelination (GO:0022010) | 7.30770531 |
| 3 | myelination (GO:0042552) | 5.66826846 |
| 4 | axon ensheathment (GO:0008366) | 5.64384376 |
| 5 | ensheathment of neurons (GO:0007272) | 5.64384376 |
| 6 | fatty acid elongation (GO:0030497) | 5.59975862 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.99432774 |
| 8 | behavioral response to nicotine (GO:0035095) | 4.96145981 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.75402874 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.73754944 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.72293710 |
| 12 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.66136191 |
| 13 | presynaptic membrane assembly (GO:0097105) | 4.57522233 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 4.53117636 |
| 15 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.49066276 |
| 16 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.45313762 |
| 17 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.45313762 |
| 18 | response to hepatocyte growth factor (GO:0035728) | 4.44721210 |
| 19 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.44721210 |
| 20 | substantia nigra development (GO:0021762) | 4.44665759 |
| 21 | response to redox state (GO:0051775) | 4.40007343 |
| 22 | transmission of nerve impulse (GO:0019226) | 4.28378230 |
| 23 | activated T cell proliferation (GO:0050798) | 4.26214655 |
| 24 | locomotory exploration behavior (GO:0035641) | 4.15005999 |
| 25 | presynaptic membrane organization (GO:0097090) | 4.14892840 |
| 26 | nucleobase catabolic process (GO:0046113) | 4.08842517 |
| 27 | L-amino acid import (GO:0043092) | 4.04488879 |
| 28 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.04356932 |
| 29 | regulation of collateral sprouting (GO:0048670) | 4.01950772 |
| 30 | auditory behavior (GO:0031223) | 3.98691648 |
| 31 | mitochondrion transport along microtubule (GO:0047497) | 3.97736543 |
| 32 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.97736543 |
| 33 | cellular response to epinephrine stimulus (GO:0071872) | 3.97127532 |
| 34 | oligodendrocyte differentiation (GO:0048709) | 3.95859152 |
| 35 | negative regulation of axon extension (GO:0030517) | 3.89415977 |
| 36 | sterol biosynthetic process (GO:0016126) | 3.88498153 |
| 37 | negative regulation of neurotransmitter transport (GO:0051589) | 3.86510263 |
| 38 | photoreceptor cell differentiation (GO:0046530) | 3.83413636 |
| 39 | eye photoreceptor cell differentiation (GO:0001754) | 3.83413636 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.81906966 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.80991171 |
| 42 | amino acid import (GO:0043090) | 3.79101931 |
| 43 | myelination in peripheral nervous system (GO:0022011) | 3.77189542 |
| 44 | peripheral nervous system axon ensheathment (GO:0032292) | 3.77189542 |
| 45 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.67704620 |
| 46 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.67278936 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.65641549 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.64863727 |
| 49 | neuronal ion channel clustering (GO:0045161) | 3.61801269 |
| 50 | glycerophospholipid catabolic process (GO:0046475) | 3.60356694 |
| 51 | mechanosensory behavior (GO:0007638) | 3.59167296 |
| 52 | response to epinephrine (GO:0071871) | 3.58824121 |
| 53 | neurofilament cytoskeleton organization (GO:0060052) | 3.58371661 |
| 54 | cell migration in hindbrain (GO:0021535) | 3.56315411 |
| 55 | positive regulation of actin filament depolymerization (GO:0030836) | 3.51966176 |
| 56 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.49942368 |
| 57 | negative regulation of axonogenesis (GO:0050771) | 3.45519546 |
| 58 | glutamate secretion (GO:0014047) | 3.43650700 |
| 59 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.41118031 |
| 60 | regulation of microtubule-based movement (GO:0060632) | 3.35626838 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.35146864 |
| 62 | synapse assembly (GO:0007416) | 3.32663227 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.31474105 |
| 64 | protein localization to synapse (GO:0035418) | 3.30466600 |
| 65 | positive regulation of gastrulation (GO:2000543) | 3.28166994 |
| 66 | isoprenoid biosynthetic process (GO:0008299) | 3.27415968 |
| 67 | neural nucleus development (GO:0048857) | 3.26896180 |
| 68 | neuron recognition (GO:0008038) | 3.24262890 |
| 69 | asymmetric protein localization (GO:0008105) | 3.24239183 |
| 70 | neuronal action potential propagation (GO:0019227) | 3.23213206 |
| 71 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.20118851 |
| 72 | Rap protein signal transduction (GO:0032486) | 3.19079430 |
| 73 | positive regulation of neurological system process (GO:0031646) | 3.19012746 |
| 74 | regulation of cilium movement (GO:0003352) | 3.18797944 |
| 75 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.18200604 |
| 76 | parturition (GO:0007567) | 3.17978887 |
| 77 | dendritic spine morphogenesis (GO:0060997) | 3.17615674 |
| 78 | apical protein localization (GO:0045176) | 3.16005290 |
| 79 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.14545112 |
| 80 | synaptic transmission, glutamatergic (GO:0035249) | 3.14025559 |
| 81 | cerebellar granule cell differentiation (GO:0021707) | 3.13597772 |
| 82 | protein palmitoylation (GO:0018345) | 3.10496915 |
| 83 | limb bud formation (GO:0060174) | 3.09297444 |
| 84 | positive regulation of growth hormone secretion (GO:0060124) | 3.09187927 |
| 85 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.09157830 |
| 86 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.08160526 |
| 87 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.08009053 |
| 88 | positive regulation of action potential (GO:0045760) | 3.06178993 |
| 89 | behavioral response to ethanol (GO:0048149) | 3.03515513 |
| 90 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.02834820 |
| 91 | neuron-neuron synaptic transmission (GO:0007270) | 3.00002034 |
| 92 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.99725403 |
| 93 | axonal fasciculation (GO:0007413) | 2.98467824 |
| 94 | brain morphogenesis (GO:0048854) | 2.96931232 |
| 95 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94368328 |
| 96 | positive regulation of neurotransmitter transport (GO:0051590) | 2.91641529 |
| 97 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.91387950 |
| 98 | dendrite morphogenesis (GO:0048813) | 2.91322579 |
| 99 | cellular response to monoamine stimulus (GO:0071868) | 2.90409955 |
| 100 | cellular response to catecholamine stimulus (GO:0071870) | 2.90409955 |
| 101 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.88806618 |
| 102 | adult walking behavior (GO:0007628) | 2.88797514 |
| 103 | positive regulation of meiosis (GO:0045836) | 2.87929945 |
| 104 | nucleotide transmembrane transport (GO:1901679) | 2.87548094 |
| 105 | neurotransmitter secretion (GO:0007269) | 2.87535683 |
| 106 | axon extension (GO:0048675) | 2.87478576 |
| 107 | protein polyglutamylation (GO:0018095) | 2.86978307 |
| 108 | glutamate receptor signaling pathway (GO:0007215) | 2.84174502 |
| 109 | creatine metabolic process (GO:0006600) | 2.83655074 |
| 110 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.83619631 |
| 111 | magnesium ion transport (GO:0015693) | 2.83122439 |
| 112 | response to methylmercury (GO:0051597) | 2.81902554 |
| 113 | spinal cord association neuron differentiation (GO:0021527) | 2.81732182 |
| 114 | regulation of female receptivity (GO:0045924) | 2.81306425 |
| 115 | astrocyte development (GO:0014002) | 2.79631408 |
| 116 | vocalization behavior (GO:0071625) | 2.79229891 |
| 117 | neuron maturation (GO:0042551) | 2.78247720 |
| 118 | response to auditory stimulus (GO:0010996) | 2.76322310 |
| 119 | tachykinin receptor signaling pathway (GO:0007217) | 2.76097397 |
| 120 | adhesion of symbiont to host cell (GO:0044650) | 2.75484913 |
| 121 | virion attachment to host cell (GO:0019062) | 2.75484913 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.75224847 |
| 123 | forebrain neuron differentiation (GO:0021879) | 2.74244171 |
| 124 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.74211503 |
| 125 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.72774131 |
| 126 | response to catecholamine (GO:0071869) | 2.72146363 |
| 127 | response to monoamine (GO:0071867) | 2.72146363 |
| 128 | membrane depolarization during action potential (GO:0086010) | 2.71989011 |
| 129 | cranial nerve development (GO:0021545) | 2.71428886 |
| 130 | neuron remodeling (GO:0016322) | 2.71424766 |
| 131 | import into cell (GO:0098657) | 2.70811400 |
| 132 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.69347142 |
| 133 | myelin maintenance (GO:0043217) | 2.69346639 |
| 134 | exploration behavior (GO:0035640) | 2.68370468 |
| 135 | negative regulation of catecholamine secretion (GO:0033604) | 2.67955495 |
| 136 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.66749735 |
| 137 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.65876211 |
| 138 | establishment of mitochondrion localization (GO:0051654) | 2.65805828 |
| 139 | response to lipoprotein particle (GO:0055094) | 2.64640957 |
| 140 | negative regulation of axon guidance (GO:1902668) | 2.64414806 |
| 141 | neuromuscular synaptic transmission (GO:0007274) | 2.63821883 |
| 142 | regulation of neurotransmitter transport (GO:0051588) | 2.63333506 |
| 143 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.62757563 |
| 144 | retinal ganglion cell axon guidance (GO:0031290) | 2.62151485 |
| 145 | positive regulation of meiotic cell cycle (GO:0051446) | 2.61048922 |
| 146 | cell differentiation in hindbrain (GO:0021533) | 2.60883060 |
| 147 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.58497115 |
| 148 | positive regulation of dendritic spine development (GO:0060999) | 2.57944883 |
| 149 | microtubule bundle formation (GO:0001578) | 2.57736466 |
| 150 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.57480043 |
| 151 | dopamine receptor signaling pathway (GO:0007212) | 2.57141353 |
| 152 | negative regulation of protein localization to cell surface (GO:2000009) | 2.56893609 |
| 153 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.56245372 |
| 154 | gamma-aminobutyric acid transport (GO:0015812) | 2.55856060 |
| 155 | striatum development (GO:0021756) | 2.53394053 |
| 156 | membrane repolarization (GO:0086009) | 2.52657630 |
| 157 | synaptic transmission, dopaminergic (GO:0001963) | 2.50548579 |
| 158 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.50254127 |
| 159 | nerve growth factor signaling pathway (GO:0038180) | 2.49249816 |
| 160 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.48857952 |
| 161 | negative regulation of interleukin-10 production (GO:0032693) | 2.48018046 |
| 162 | synaptic vesicle exocytosis (GO:0016079) | 2.44855118 |
| 163 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.44306571 |
| 164 | peripheral nervous system development (GO:0007422) | 2.44146702 |
| 165 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43856483 |
| 166 | postsynaptic membrane organization (GO:0001941) | 2.43306876 |
| 167 | regulation of myelination (GO:0031641) | 2.42153715 |
| 168 | ER overload response (GO:0006983) | 2.41783702 |
| 169 | positive regulation of synapse assembly (GO:0051965) | 2.40966116 |
| 170 | neurotransmitter catabolic process (GO:0042135) | 2.40704101 |
| 171 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.39538469 |
| 172 | synapse organization (GO:0050808) | 2.39101425 |
| 173 | regulation of transmission of nerve impulse (GO:0051969) | 2.38818371 |
| 174 | spinal cord motor neuron differentiation (GO:0021522) | 2.37944057 |
| 175 | regulation of extent of cell growth (GO:0061387) | 2.35703910 |
| 176 | membrane assembly (GO:0071709) | 2.34819293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.66552805 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45649720 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61376382 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.55135218 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.52346749 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.41529874 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38002210 |
| 8 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.35703668 |
| 9 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33254377 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11854291 |
| 11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.10606832 |
| 12 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.10606832 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09566400 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09086260 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07736903 |
| 16 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05166132 |
| 17 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05113889 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.04887315 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.03673090 |
| 20 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.98106036 |
| 21 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97799322 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95439121 |
| 23 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95322922 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92702622 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91395630 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90433318 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89944159 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.89283628 |
| 29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.89117677 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88786342 |
| 31 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88757016 |
| 32 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.85615338 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83289203 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80231770 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77531395 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74028325 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63172122 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62271755 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59983101 |
| 40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58979490 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58922314 |
| 42 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54062476 |
| 43 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.52719071 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52453120 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50726353 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49280234 |
| 47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.47010322 |
| 48 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44116050 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43040907 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42918193 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.42717235 |
| 52 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41047066 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39974348 |
| 54 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.36837892 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36159362 |
| 56 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34957932 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31546160 |
| 58 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29859860 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29614037 |
| 60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28810042 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28760794 |
| 62 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28066352 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25813203 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25512450 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25274368 |
| 66 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.24313821 |
| 67 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24240400 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24108911 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24108911 |
| 70 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22770688 |
| 71 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21020805 |
| 72 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20889777 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20542437 |
| 74 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16073532 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15313028 |
| 76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14049051 |
| 77 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13807680 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12116476 |
| 79 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11987457 |
| 80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.11965302 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10043961 |
| 82 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09736148 |
| 83 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09619473 |
| 84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08020622 |
| 85 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06732827 |
| 86 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02070816 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01495715 |
| 88 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01312737 |
| 89 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01069367 |
| 90 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99973133 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99528140 |
| 92 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98613966 |
| 93 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98240394 |
| 94 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.97723780 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97487343 |
| 96 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97136991 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96519949 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96117491 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95723637 |
| 100 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95527314 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94991207 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94886702 |
| 103 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94603832 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94438813 |
| 105 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94371875 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93751734 |
| 107 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.93525117 |
| 108 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93020963 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92912233 |
| 110 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91442161 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91438537 |
| 112 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.90872407 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90493872 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88374560 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88254140 |
| 116 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.88247102 |
| 117 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.87720026 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86937070 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86937070 |
| 120 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.85697515 |
| 121 | AR_19668381_ChIP-Seq_PC3_Human | 0.84884090 |
| 122 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.84316709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.38459395 |
| 2 | MP0000920_abnormal_myelination | 3.99281947 |
| 3 | MP0003123_paternal_imprinting | 3.13805749 |
| 4 | MP0004270_analgesia | 3.00017657 |
| 5 | MP0004742_abnormal_vestibular_system | 2.88842721 |
| 6 | MP0003690_abnormal_glial_cell | 2.67171490 |
| 7 | MP0001529_abnormal_vocalization | 2.61612700 |
| 8 | MP0002272_abnormal_nervous_system | 2.58112841 |
| 9 | MP0001486_abnormal_startle_reflex | 2.50065677 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.47746280 |
| 11 | MP0002064_seizures | 2.45917728 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.45264515 |
| 13 | MP0000778_abnormal_nervous_system | 2.43430548 |
| 14 | MP0003121_genomic_imprinting | 2.36230082 |
| 15 | MP0002822_catalepsy | 2.33040762 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.33015920 |
| 17 | MP0000462_abnormal_digestive_system | 2.27865076 |
| 18 | MP0005171_absent_coat_pigmentation | 2.24166723 |
| 19 | MP0001485_abnormal_pinna_reflex | 2.20646559 |
| 20 | MP0004885_abnormal_endolymph | 2.20333292 |
| 21 | MP0001905_abnormal_dopamine_level | 2.16771615 |
| 22 | MP0009046_muscle_twitch | 2.16675790 |
| 23 | MP0003329_amyloid_beta_deposits | 2.14604202 |
| 24 | MP0009745_abnormal_behavioral_response | 2.10458151 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.05891831 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.00930752 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.00815166 |
| 28 | MP0003634_abnormal_glial_cell | 2.00631801 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.91385705 |
| 30 | MP0005499_abnormal_olfactory_system | 1.88233635 |
| 31 | MP0005394_taste/olfaction_phenotype | 1.88233635 |
| 32 | MP0003879_abnormal_hair_cell | 1.82923733 |
| 33 | MP0004142_abnormal_muscle_tone | 1.82617344 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.81271603 |
| 35 | MP0005409_darkened_coat_color | 1.78056493 |
| 36 | MP0002063_abnormal_learning/memory/cond | 1.73630249 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.72663125 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.65597670 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.64189176 |
| 40 | MP0002229_neurodegeneration | 1.63502556 |
| 41 | MP0000955_abnormal_spinal_cord | 1.62622174 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.61694388 |
| 43 | MP0003136_yellow_coat_color | 1.61417785 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.57544385 |
| 45 | MP0002163_abnormal_gland_morphology | 1.49807239 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.49591295 |
| 47 | MP0004134_abnormal_chest_morphology | 1.48341618 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.47210917 |
| 49 | MP0002184_abnormal_innervation | 1.46432833 |
| 50 | MP0003632_abnormal_nervous_system | 1.46277088 |
| 51 | MP0004043_abnormal_pH_regulation | 1.45406995 |
| 52 | MP0005551_abnormal_eye_electrophysiolog | 1.43082324 |
| 53 | MP0008569_lethality_at_weaning | 1.42391898 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.41353348 |
| 55 | MP0004924_abnormal_behavior | 1.41353348 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.40939994 |
| 57 | MP0001299_abnormal_eye_distance/ | 1.40845912 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.40806900 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.38522513 |
| 60 | MP0001970_abnormal_pain_threshold | 1.37920396 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.37762080 |
| 62 | MP0002066_abnormal_motor_capabilities/c | 1.37722258 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.35622582 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.31906960 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.31045586 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.30466334 |
| 67 | MP0000566_synostosis | 1.28863059 |
| 68 | MP0002752_abnormal_somatic_nervous | 1.25327542 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.18267161 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.17791084 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 1.16641140 |
| 72 | MP0003195_calcinosis | 1.16493960 |
| 73 | MP0009780_abnormal_chondrocyte_physiolo | 1.13452241 |
| 74 | MP0003122_maternal_imprinting | 1.13018159 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.10486427 |
| 76 | MP0005253_abnormal_eye_physiology | 1.07463632 |
| 77 | MP0001984_abnormal_olfaction | 1.05050409 |
| 78 | MP0001501_abnormal_sleep_pattern | 1.04848636 |
| 79 | MP0005646_abnormal_pituitary_gland | 1.04293738 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.01912850 |
| 81 | MP0002653_abnormal_ependyma_morphology | 1.00861783 |
| 82 | MP0008995_early_reproductive_senescence | 1.00852630 |
| 83 | MP0002152_abnormal_brain_morphology | 1.00534709 |
| 84 | MP0003283_abnormal_digestive_organ | 1.00124993 |
| 85 | MP0002160_abnormal_reproductive_system | 0.98771045 |
| 86 | MP0003011_delayed_dark_adaptation | 0.98736950 |
| 87 | MP0001661_extended_life_span | 0.97945349 |
| 88 | MP0005187_abnormal_penis_morphology | 0.96346734 |
| 89 | MP0002736_abnormal_nociception_after | 0.96307753 |
| 90 | MP0000026_abnormal_inner_ear | 0.94901367 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.93725077 |
| 92 | MP0003631_nervous_system_phenotype | 0.93050352 |
| 93 | MP0002928_abnormal_bile_duct | 0.92450869 |
| 94 | MP0002090_abnormal_vision | 0.91525341 |
| 95 | MP0005195_abnormal_posterior_eye | 0.90921535 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.89167522 |
| 97 | MP0002751_abnormal_autonomic_nervous | 0.87518705 |
| 98 | MP0005310_abnormal_salivary_gland | 0.87456111 |
| 99 | MP0005410_abnormal_fertilization | 0.86421729 |
| 100 | MP0000604_amyloidosis | 0.85458372 |
| 101 | MP0004133_heterotaxia | 0.85379064 |
| 102 | MP0001177_atelectasis | 0.83269013 |
| 103 | MP0003868_abnormal_feces_composition | 0.82478942 |
| 104 | MP0004811_abnormal_neuron_physiology | 0.82378494 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.81349630 |
| 106 | MP0001919_abnormal_reproductive_system | 0.79549975 |
| 107 | MP0005389_reproductive_system_phenotype | 0.79241785 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.78532637 |
| 109 | MP0005535_abnormal_body_temperature | 0.78216816 |
| 110 | MP0003938_abnormal_ear_development | 0.77164547 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.76458082 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.76291767 |
| 113 | MP0003861_abnormal_nervous_system | 0.75700317 |
| 114 | MP0003633_abnormal_nervous_system | 0.75672343 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.74422394 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 0.74357989 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.73395591 |
| 118 | MP0002938_white_spotting | 0.72847283 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.72444040 |
| 120 | MP0004085_abnormal_heartbeat | 0.72055562 |
| 121 | MP0005451_abnormal_body_composition | 0.71471219 |
| 122 | MP0003787_abnormal_imprinting | 0.70762520 |
| 123 | MP0001188_hyperpigmentation | 0.69468238 |
| 124 | MP0002102_abnormal_ear_morphology | 0.69012820 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.68409324 |
| 126 | MP0001756_abnormal_urination | 0.68185051 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.67958420 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.67539357 |
| 129 | MP0000427_abnormal_hair_cycle | 0.66654561 |
| 130 | MP0008872_abnormal_physiological_respon | 0.65753206 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.62951689 |
| 132 | MP0005448_abnormal_energy_balance | 0.62746776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.71080578 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.71080578 |
| 3 | Sensory axonal neuropathy (HP:0003390) | 5.26961186 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.91559190 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.54883690 |
| 6 | Polyphagia (HP:0002591) | 4.46286047 |
| 7 | Agitation (HP:0000713) | 4.04111200 |
| 8 | Parakeratosis (HP:0001036) | 4.03283247 |
| 9 | Abnormal pancreas size (HP:0012094) | 3.97013306 |
| 10 | Atonic seizures (HP:0010819) | 3.88276296 |
| 11 | Peripheral hypomyelination (HP:0007182) | 3.52639214 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.42007519 |
| 13 | Akinesia (HP:0002304) | 3.41629548 |
| 14 | Spastic gait (HP:0002064) | 3.33283819 |
| 15 | Abnormality of the parathyroid morphology (HP:0011766) | 3.32818472 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.26141694 |
| 17 | Abnormal eating behavior (HP:0100738) | 3.14305622 |
| 18 | Alacrima (HP:0000522) | 3.05253124 |
| 19 | Gait imbalance (HP:0002141) | 3.04161665 |
| 20 | Medial flaring of the eyebrow (HP:0010747) | 3.02677453 |
| 21 | Intention tremor (HP:0002080) | 3.01507190 |
| 22 | Drooling (HP:0002307) | 2.97726516 |
| 23 | Small epiphyses (HP:0010585) | 2.95903862 |
| 24 | Pheochromocytoma (HP:0002666) | 2.92695624 |
| 25 | Neoplasm of the adrenal cortex (HP:0100641) | 2.91648362 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.88929859 |
| 27 | Hyperthyroidism (HP:0000836) | 2.87807874 |
| 28 | Nephronophthisis (HP:0000090) | 2.86102283 |
| 29 | Febrile seizures (HP:0002373) | 2.84653573 |
| 30 | Dysmetria (HP:0001310) | 2.78715831 |
| 31 | Abnormality of glycolysis (HP:0004366) | 2.76407718 |
| 32 | Increased serum pyruvate (HP:0003542) | 2.76407718 |
| 33 | Hepatoblastoma (HP:0002884) | 2.72641698 |
| 34 | Cerebral hypomyelination (HP:0006808) | 2.72246003 |
| 35 | Congenital stationary night blindness (HP:0007642) | 2.72020479 |
| 36 | Excessive salivation (HP:0003781) | 2.71023941 |
| 37 | Anteriorly placed anus (HP:0001545) | 2.68593334 |
| 38 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.67481576 |
| 39 | Increased circulating renin level (HP:0000848) | 2.63964566 |
| 40 | Scanning speech (HP:0002168) | 2.61444761 |
| 41 | Retinal dysplasia (HP:0007973) | 2.60754032 |
| 42 | Premature skin wrinkling (HP:0100678) | 2.60248085 |
| 43 | Molar tooth sign on MRI (HP:0002419) | 2.56928355 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.56928355 |
| 45 | Pachygyria (HP:0001302) | 2.55804832 |
| 46 | Neuroendocrine neoplasm (HP:0100634) | 2.55172207 |
| 47 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.52363094 |
| 48 | Cupped ear (HP:0000378) | 2.50292724 |
| 49 | Decreased lacrimation (HP:0000633) | 2.50183177 |
| 50 | Metaphyseal dysplasia (HP:0100255) | 2.49664720 |
| 51 | Abnormality of macular pigmentation (HP:0008002) | 2.44997136 |
| 52 | Leukodystrophy (HP:0002415) | 2.42227299 |
| 53 | Abnormality of the renal medulla (HP:0100957) | 2.40979394 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.39481286 |
| 55 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.38702755 |
| 56 | Spastic tetraplegia (HP:0002510) | 2.35382554 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.35051958 |
| 58 | Focal motor seizures (HP:0011153) | 2.33460530 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.31911113 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.28049760 |
| 61 | Hemiparesis (HP:0001269) | 2.26973455 |
| 62 | Enlarged penis (HP:0000040) | 2.26731117 |
| 63 | Cerebral hemorrhage (HP:0001342) | 2.26196410 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25740082 |
| 65 | Growth hormone deficiency (HP:0000824) | 2.24884267 |
| 66 | Renal Fanconi syndrome (HP:0001994) | 2.24283978 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.22489784 |
| 68 | Termporal pattern (HP:0011008) | 2.21782139 |
| 69 | Insidious onset (HP:0003587) | 2.21782139 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.20028123 |
| 71 | Onion bulb formation (HP:0003383) | 2.19206150 |
| 72 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19159570 |
| 73 | Poor suck (HP:0002033) | 2.18233142 |
| 74 | Abnormality of the labia minora (HP:0012880) | 2.17299239 |
| 75 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17139761 |
| 76 | Anomalous pulmonary venous return (HP:0010772) | 2.16810485 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.16673861 |
| 78 | Generalized tonic-clonic seizures (HP:0002069) | 2.15908584 |
| 79 | Failure to thrive in infancy (HP:0001531) | 2.15734602 |
| 80 | True hermaphroditism (HP:0010459) | 2.15486578 |
| 81 | Genetic anticipation (HP:0003743) | 2.14721808 |
| 82 | Hypoplastic pelvis (HP:0008839) | 2.11927113 |
| 83 | Pancreatic fibrosis (HP:0100732) | 2.11763932 |
| 84 | Ankle clonus (HP:0011448) | 2.11566178 |
| 85 | Focal seizures (HP:0007359) | 2.11403772 |
| 86 | Myokymia (HP:0002411) | 2.09905696 |
| 87 | Abnormal drinking behavior (HP:0030082) | 2.09312271 |
| 88 | Polydipsia (HP:0001959) | 2.09312271 |
| 89 | Hypomagnesemia (HP:0002917) | 2.08730957 |
| 90 | Poor speech (HP:0002465) | 2.06861028 |
| 91 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.05918333 |
| 92 | Oligodactyly (hands) (HP:0001180) | 2.05319236 |
| 93 | Lissencephaly (HP:0001339) | 2.05049969 |
| 94 | Action tremor (HP:0002345) | 2.04126342 |
| 95 | Acute necrotizing encephalopathy (HP:0006965) | 2.03922803 |
| 96 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.03906956 |
| 97 | Deep palmar crease (HP:0006191) | 2.03685356 |
| 98 | Focal dystonia (HP:0004373) | 2.00270228 |
| 99 | Thickened helices (HP:0000391) | 1.99957778 |
| 100 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97815235 |
| 101 | Broad-based gait (HP:0002136) | 1.97809641 |
| 102 | Lower limb muscle weakness (HP:0007340) | 1.97306693 |
| 103 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.97296491 |
| 104 | Hypoplasia of the brainstem (HP:0002365) | 1.97296491 |
| 105 | Abnormal auditory evoked potentials (HP:0006958) | 1.97255844 |
| 106 | Epileptic encephalopathy (HP:0200134) | 1.96597986 |
| 107 | Progressive inability to walk (HP:0002505) | 1.96040222 |
| 108 | Sleep apnea (HP:0010535) | 1.95952006 |
| 109 | Tubular atrophy (HP:0000092) | 1.94423678 |
| 110 | Tubulointerstitial nephritis (HP:0001970) | 1.94336506 |
| 111 | Amblyopia (HP:0000646) | 1.93926466 |
| 112 | Clumsiness (HP:0002312) | 1.93718308 |
| 113 | Type II lissencephaly (HP:0007260) | 1.93346739 |
| 114 | Vaginal atresia (HP:0000148) | 1.92801336 |
| 115 | Restlessness (HP:0000711) | 1.92528437 |
| 116 | Torticollis (HP:0000473) | 1.91581628 |
| 117 | Widely spaced teeth (HP:0000687) | 1.91318064 |
| 118 | Progressive cerebellar ataxia (HP:0002073) | 1.91148498 |
| 119 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.90664482 |
| 120 | Chronic hepatic failure (HP:0100626) | 1.90037481 |
| 121 | Synostosis involving the elbow (HP:0003938) | 1.89580075 |
| 122 | Humeroradial synostosis (HP:0003041) | 1.89580075 |
| 123 | Specific learning disability (HP:0001328) | 1.88714269 |
| 124 | Epiphyseal dysplasia (HP:0002656) | 1.88526336 |
| 125 | Absent septum pellucidum (HP:0001331) | 1.87867480 |
| 126 | Chin dimple (HP:0010751) | 1.87451363 |
| 127 | Dialeptic seizures (HP:0011146) | 1.86971026 |
| 128 | Hyperphosphatemia (HP:0002905) | 1.86290263 |
| 129 | Pancreatic cysts (HP:0001737) | 1.86184839 |
| 130 | Anxiety (HP:0000739) | 1.85456805 |
| 131 | Mixed hearing impairment (HP:0000410) | 1.83858243 |
| 132 | Genital tract atresia (HP:0001827) | 1.83478304 |
| 133 | White forelock (HP:0002211) | 1.82636772 |
| 134 | Limb dystonia (HP:0002451) | 1.82327473 |
| 135 | Adrenal hypoplasia (HP:0000835) | 1.81436105 |
| 136 | Autoamputation (HP:0001218) | 1.81216240 |
| 137 | Split foot (HP:0001839) | 1.81054425 |
| 138 | Abnormality of the pulmonary veins (HP:0011718) | 1.80278473 |
| 139 | Anosmia (HP:0000458) | 1.80249325 |
| 140 | Abnormality of the lower motor neuron (HP:0002366) | 1.79804103 |
| 141 | Bowel incontinence (HP:0002607) | 1.79722359 |
| 142 | Poor coordination (HP:0002370) | 1.79564652 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.79383118 |
| 144 | Spastic paraparesis (HP:0002313) | 1.78959654 |
| 145 | Patchy hypopigmentation of hair (HP:0011365) | 1.78670710 |
| 146 | Septo-optic dysplasia (HP:0100842) | 1.78332403 |
| 147 | Blue irides (HP:0000635) | 1.77837875 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.77485973 |
| 149 | Congenital malformation of the right heart (HP:0011723) | 1.77358223 |
| 150 | Double outlet right ventricle (HP:0001719) | 1.77358223 |
| 151 | Clonus (HP:0002169) | 1.75603243 |
| 152 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75523469 |
| 153 | Status epilepticus (HP:0002133) | 1.75484965 |
| 154 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.75459848 |
| 155 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75392360 |
| 156 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75346473 |
| 157 | Severe visual impairment (HP:0001141) | 1.74682571 |
| 158 | Abnormality of renin-angiotensin system (HP:0000847) | 1.74569368 |
| 159 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73978521 |
| 160 | Abnormality of incisor morphology (HP:0011063) | 1.71941877 |
| 161 | Partial agenesis of the corpus callosum (HP:0001338) | 1.68994109 |
| 162 | Absent speech (HP:0001344) | 1.68494259 |
| 163 | Hyperventilation (HP:0002883) | 1.67740893 |
| 164 | Visual hallucinations (HP:0002367) | 1.67239985 |
| 165 | Decreased central vision (HP:0007663) | 1.66818834 |
| 166 | Absent/shortened dynein arms (HP:0200106) | 1.65964381 |
| 167 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.65964381 |
| 168 | Absence seizures (HP:0002121) | 1.65544907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.20862841 |
| 2 | TNIK | 4.57418296 |
| 3 | OXSR1 | 3.49866039 |
| 4 | EPHB1 | 3.14432159 |
| 5 | PINK1 | 2.85268146 |
| 6 | BCR | 2.84903631 |
| 7 | UHMK1 | 2.55528125 |
| 8 | WNK4 | 2.54434454 |
| 9 | DAPK2 | 2.50591190 |
| 10 | PKN1 | 2.43709062 |
| 11 | TYRO3 | 2.41799414 |
| 12 | CASK | 2.39880128 |
| 13 | FRK | 2.04639912 |
| 14 | MAPK13 | 2.01359915 |
| 15 | IRAK2 | 2.00837657 |
| 16 | ICK | 1.92527144 |
| 17 | MARK1 | 1.87844584 |
| 18 | LIMK1 | 1.81975985 |
| 19 | PRPF4B | 1.79359136 |
| 20 | NTRK1 | 1.79330087 |
| 21 | FES | 1.77984441 |
| 22 | ZAK | 1.70764694 |
| 23 | WNK1 | 1.68968975 |
| 24 | CDK19 | 1.62089822 |
| 25 | IRAK1 | 1.57384676 |
| 26 | FGFR2 | 1.49796432 |
| 27 | SGK2 | 1.48466611 |
| 28 | SIK2 | 1.47840911 |
| 29 | CSNK1G3 | 1.47107687 |
| 30 | NEK6 | 1.42845891 |
| 31 | NTRK3 | 1.37150823 |
| 32 | MET | 1.36962828 |
| 33 | INSRR | 1.34002221 |
| 34 | PNCK | 1.33545309 |
| 35 | ROCK2 | 1.32913911 |
| 36 | CSNK1A1L | 1.32148484 |
| 37 | PAK6 | 1.24035283 |
| 38 | IRAK4 | 1.23787530 |
| 39 | FGR | 1.20535166 |
| 40 | CAMKK1 | 1.19433477 |
| 41 | CSNK1G2 | 1.16464942 |
| 42 | CSNK1G1 | 1.14196568 |
| 43 | DYRK2 | 1.12877019 |
| 44 | MAP3K2 | 1.12450325 |
| 45 | PAK3 | 1.07834370 |
| 46 | MAP2K4 | 1.06625768 |
| 47 | MST4 | 1.05203061 |
| 48 | GRK1 | 1.05197978 |
| 49 | DYRK3 | 1.05112942 |
| 50 | CAMK2B | 1.04497821 |
| 51 | MAPK15 | 1.02990418 |
| 52 | CAMK2D | 1.01681354 |
| 53 | EPHA4 | 1.00707308 |
| 54 | BRAF | 0.89503837 |
| 55 | SGK3 | 0.89252646 |
| 56 | CDK5 | 0.88585739 |
| 57 | PRKCQ | 0.86932521 |
| 58 | CLK1 | 0.85802199 |
| 59 | NTRK2 | 0.85223890 |
| 60 | SGK494 | 0.80791099 |
| 61 | SGK223 | 0.80791099 |
| 62 | PBK | 0.80501405 |
| 63 | CAMK2A | 0.79429712 |
| 64 | AKT3 | 0.78497834 |
| 65 | RPS6KA2 | 0.78338060 |
| 66 | TAOK3 | 0.74950072 |
| 67 | MAP3K11 | 0.73496804 |
| 68 | HIPK2 | 0.72761577 |
| 69 | TIE1 | 0.70271080 |
| 70 | ROCK1 | 0.69572118 |
| 71 | CDK14 | 0.68074165 |
| 72 | PRKCE | 0.67988724 |
| 73 | MINK1 | 0.67934192 |
| 74 | MAP3K4 | 0.67770669 |
| 75 | FYN | 0.67655678 |
| 76 | WNK3 | 0.67240684 |
| 77 | PLK2 | 0.66500945 |
| 78 | MARK2 | 0.66023208 |
| 79 | EPHB2 | 0.64728588 |
| 80 | PDGFRB | 0.63563851 |
| 81 | PRKCZ | 0.61059407 |
| 82 | MAP2K7 | 0.60461657 |
| 83 | PRKD3 | 0.56982706 |
| 84 | CSNK1E | 0.56353860 |
| 85 | PRKCH | 0.55882124 |
| 86 | TRIM28 | 0.54987381 |
| 87 | CAMK2G | 0.54511835 |
| 88 | MAP3K9 | 0.52172672 |
| 89 | LMTK2 | 0.51680481 |
| 90 | MAPKAPK5 | 0.50573384 |
| 91 | GRK5 | 0.50427496 |
| 92 | CDK15 | 0.49321764 |
| 93 | PTK2 | 0.49146808 |
| 94 | CSK | 0.49131131 |
| 95 | MAP3K6 | 0.49008006 |
| 96 | CAMK1 | 0.48886600 |
| 97 | SGK1 | 0.48871659 |
| 98 | CDK18 | 0.48528339 |
| 99 | ADRBK1 | 0.47783098 |
| 100 | ADRBK2 | 0.46507013 |
| 101 | PHKG2 | 0.46305578 |
| 102 | PHKG1 | 0.46305578 |
| 103 | BMPR1B | 0.46287963 |
| 104 | GSK3A | 0.46284619 |
| 105 | NUAK1 | 0.45227747 |
| 106 | ERBB4 | 0.45190387 |
| 107 | PDPK1 | 0.44643513 |
| 108 | PRKG1 | 0.44567197 |
| 109 | ARAF | 0.44246087 |
| 110 | TNK2 | 0.43928086 |
| 111 | CDC42BPA | 0.43856934 |
| 112 | PRKACA | 0.43071578 |
| 113 | OBSCN | 0.42841822 |
| 114 | CDK11A | 0.42741302 |
| 115 | CAMK1G | 0.41009640 |
| 116 | KSR1 | 0.40753510 |
| 117 | PRKCG | 0.40735514 |
| 118 | INSR | 0.40268957 |
| 119 | CSNK1A1 | 0.40182730 |
| 120 | DYRK1B | 0.39812715 |
| 121 | EPHA3 | 0.38910564 |
| 122 | BMPR2 | 0.38589495 |
| 123 | STK16 | 0.38251925 |
| 124 | BRD4 | 0.38077336 |
| 125 | DYRK1A | 0.37803971 |
| 126 | PRKCA | 0.37089408 |
| 127 | GRK7 | 0.36749051 |
| 128 | CAMKK2 | 0.36234000 |
| 129 | RPS6KA3 | 0.35486604 |
| 130 | ITK | 0.35343748 |
| 131 | ABL2 | 0.35022992 |
| 132 | MAP3K13 | 0.34751574 |
| 133 | CSNK1D | 0.34232582 |
| 134 | DMPK | 0.34088360 |
| 135 | KSR2 | 0.33616200 |
| 136 | PRKD1 | 0.32443794 |
| 137 | MUSK | 0.30858034 |
| 138 | STK11 | 0.28632738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.83604790 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.00434657 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.28820827 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.74019434 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.49437676 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.46625890 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.28972050 |
| 8 | Axon guidance_Homo sapiens_hsa04360 | 2.12625797 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.04157638 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.02588867 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01438315 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.88715446 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.87113922 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.81999956 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72958429 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.70479318 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.67876120 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66788898 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61877011 |
| 20 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.61140397 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.60506087 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56974179 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.55775470 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.49260091 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.44810338 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42789757 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.40621822 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29241681 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.28368122 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28215834 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.27127219 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.25990794 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24790285 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24495664 |
| 35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12058537 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08281306 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07969647 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.03574148 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02552144 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02400663 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02145469 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.98258213 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96677522 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96561648 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95193127 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91314741 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89799859 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 0.87973616 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87933405 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82221246 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82025660 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79528599 |
| 53 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79188160 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74325651 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73733490 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73336682 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.72766617 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71965413 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71962613 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.71080911 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70205788 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69829530 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69746553 |
| 64 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67716248 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67471877 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65816272 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64795938 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64031970 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63411334 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.63032863 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.62056359 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.61848014 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61174059 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60704664 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60092354 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58676447 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.57927367 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.57774617 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.57098121 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.55396376 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54582003 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53853026 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53517224 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53446851 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48814509 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47632433 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47275624 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46797756 |
| 89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46085680 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46004323 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45887252 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45692405 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45526607 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44055579 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42869034 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42570977 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41891563 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.41881654 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41481548 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40499245 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39522580 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39246088 |
| 103 | Peroxisome_Homo sapiens_hsa04146 | 0.36648606 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36476965 |
| 105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36293570 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34836500 |
| 107 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.34522039 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34175360 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33870822 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33636789 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33174646 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33117487 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31917872 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30821205 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30351874 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30111779 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29507483 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29012325 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28251377 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.28107488 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27902576 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27456365 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27061712 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26005081 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24143212 |

